National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia; Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia; Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.
Am J Cardiol. 2014 Mar 15;113(6):1036-40. doi: 10.1016/j.amjcard.2013.11.066. Epub 2013 Dec 27.
Prenatal diagnosis has been shown to improve preoperative morbidity in newborns with congenital heart defects (CHDs), but there are conflicting data as to the association with mortality. We performed a population-based, retrospective, cohort study of infants with prenatally versus postnatally diagnosed CHDs from 1994 to 2005 as ascertained by the Metropolitan Atlanta Congenital Defects Program. Among infants with isolated CHDs, we estimated 1-year Kaplan-Meier survival probabilities for prenatal versus postnatal diagnosis and estimated Cox proportional hazard ratios adjusted for critical CHD status, gestational age, and maternal race/ethnicity. Of 539,519 live births, 4,348 infants had CHDs (411 prenatally diagnosed). Compared with those with noncritical defects, those with critical defects were more likely to be prenatally diagnosed (58% vs 20%, respectively, p <0.001). Of the 3,146 infants with isolated CHDs, 1-year survival rate was 77% for those prenatally diagnosed (n = 207) versus 96% for those postnatally diagnosed (n = 2,939, p <0.001). Comparing 1-year survival rate among those with noncritical CHDs alone (n = 2,455) showed no difference between prenatal and postnatal diagnoses (96% vs 98%, respectively, p = 0.26), whereas among those with critical CHDs (n = 691), prenatally diagnosed infants had significantly lower survival rate (71% vs 86%, respectively, p <0.001). Among infants with critical CHDs, the adjusted hazard ratio for 1-year mortality rate for those prenatally versus postnatally (reference) diagnosed was 2.51 (95% confidence interval 1.72 to 3.66). In conclusion, prenatal diagnosis is associated with lower 1-year survival rate for infants with isolated critical CHDs but shows no change for those with isolated noncritical CHDs. More severe disease among the critical CHD subtypes diagnosed prenatally might explain these findings.
产前诊断已被证明可降低先天性心脏病(CHD)新生儿的术前发病率,但关于其与死亡率的关联仍存在数据冲突。我们对 1994 年至 2005 年间通过亚特兰大都市先天性缺陷计划确定的、产前或产后诊断的 CHD 婴儿进行了一项基于人群的回顾性队列研究。在孤立性 CHD 婴儿中,我们估计了产前与产后诊断的 1 年 Kaplan-Meier 生存概率,并根据关键 CHD 状态、胎龄和产妇种族/民族调整了 Cox 比例风险比。在 539519 例活产儿中,有 4348 例婴儿患有 CHD(411 例产前诊断)。与非关键缺陷相比,关键缺陷更有可能在产前诊断(分别为 58%和 20%,p <0.001)。在 3146 例孤立性 CHD 婴儿中,产前诊断的 1 年生存率为 77%(n = 207),产后诊断的为 96%(n = 2939,p <0.001)。比较单独具有非关键 CHD 的婴儿(n = 2455)的 1 年生存率,产前和产后诊断之间无差异(分别为 96%和 98%,p = 0.26),而在具有关键 CHD 的婴儿(n = 691)中,产前诊断的婴儿生存率明显较低(分别为 71%和 86%,p <0.001)。在具有关键 CHD 的婴儿中,与产后诊断相比,产前诊断的 1 年死亡率调整后的危险比为 2.51(95%置信区间 1.72 至 3.66)。总之,产前诊断与孤立性严重 CHD 婴儿的 1 年生存率降低相关,但与孤立性非关键 CHD 婴儿的生存率无变化相关。产前诊断的严重 CHD 亚型中更严重的疾病可能解释了这些发现。